Analysts Set Agilon Health, Inc. (NYSE:AGL) PT at $4.71

Agilon Health, Inc. (NYSE:AGL - Get Free Report) has earned a consensus recommendation of "Hold" from the eighteen research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $4.71.

AGL has been the topic of a number of research analyst reports. Needham & Company LLC restated a "hold" rating on shares of Agilon Health in a research report on Friday, March 21st. Sanford C. Bernstein raised Agilon Health from a "market perform" rating to an "outperform" rating and increased their price target for the company from $3.30 to $8.50 in a report on Tuesday, April 8th. Barclays increased their price target on Agilon Health from $2.00 to $3.00 and gave the company an "underweight" rating in a report on Thursday, May 8th. TD Cowen increased their price target on Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a report on Tuesday, April 15th. Finally, Evercore ISI lowered their price target on Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a report on Wednesday, July 9th.

Agilon Health Stock Up 2.0%

Shares of AGL stock traded up $0.05 during mid-day trading on Friday, reaching $2.28. 144,161 shares of the company's stock traded hands, compared to its average volume of 5,229,884. Agilon Health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a market cap of $941.74 million, a P/E ratio of -3.84 and a beta of 0.16. The company's 50-day moving average price is $2.44 and its 200-day moving average price is $3.25.

Agilon Health (NYSE:AGL - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The firm had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.50 billion. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The company's quarterly revenue was down 4.5% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.02) EPS. Equities analysts predict that Agilon Health will post -0.59 earnings per share for the current year.

Institutional Trading of Agilon Health

Institutional investors have recently added to or reduced their stakes in the company. Capital International Investors boosted its holdings in shares of Agilon Health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC increased its position in shares of Agilon Health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after acquiring an additional 4,706,357 shares during the period. Nuveen LLC acquired a new position in shares of Agilon Health in the 1st quarter valued at $17,242,000. Algert Global LLC increased its position in shares of Agilon Health by 1,042.7% in the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after acquiring an additional 1,924,157 shares during the period. Finally, CenterBook Partners LP acquired a new stake in Agilon Health during the 1st quarter worth about $8,315,000.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.